Skip to content

A randomized, placebo-controlled, double-blind,multicenter trial research for 'Xitongkang' in the treatment of Knee osteoarthritis (kidney deficiency and blood stasis syndrome)

A randomized, placebo-controlled, double-blind,multicenter trial research for 'Xitongkang' in the treatment of Knee osteoarthritis (kidney deficiency and blood stasis syndrome)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010706
Enrollment
Unknown
Registered
2017-02-22
Start date
2017-02-10
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

knee osteoarthritis

Interventions

experimental group:Xitongkang+basic treatment

Sponsors

The affiliated hospital of Liaoning University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Western medicine diagnosis accord with KOA;K-L=3 grade, TCM diagnosis accord with heumatism(kidney deficiency and blood stasis syndrome); 2. Aged 50 to 70 years; 3. Patients who can provide telephone number and cooperate with doctors without moving; 4. Voluntarism and sign.

Exclusion criteria

Exclusion criteria: 1. With Acute knee joint injuryAcute Suppurative Kneetuberculosis of knee joint and knee tumor; 2. The late knee osteoarthropathy; 3. With inside and outside double deformity of knee joint and damage of blood and nerve; 4. With disease of heartbrainlungliverkidney internal secretion and hemopoietic system. With abnormal liver and renal function; 5. Pregnancy and nursing mothers; 6. Patients with disability in law; 7. Those who can not understand the treatment or can not take medicine and the relevant inspectors on time; 8. Those who receive treatments within two weeks; 9. Those who participate other trail research; 10. Those who may or can make sure have alcohol and drug abuse history; 11. Those who can make complicated of the trial, for example, moving of work and instability of environment.

Design outcomes

Primary

MeasureTime frame
blood routine examination;routine urine test;stool test;liver function;renal function (creatinine);electrocardiogram;The knee joint X-ray;

Secondary

MeasureTime frame
Four blood coagulation indexes;

Countries

China

Contacts

Public ContactGuan Xuefeng

The affiliated hospital of Liaoning University of traditional Chinese Medicine

lnzygxf@163.com+86 13304018111

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026